Effects of astrocytic PKM2 gene deletion on neuronal death following traumatic brain injury.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model study
PubMed 41213921 · doi:10.1038/s41420-025-02829-7
What was done
Researchers evaluated the role of astrocytic pyruvate kinase M2 (PKM2) and the astrocyte-neuron lactate shuttle in traumatic brain injury (TBI). Tamoxifen-inducible astrocyte-specific PKM2 knockout mice (Aldh1l1-Cre ERT2 ; PKM2 f/f) underwent experimental TBI, followed by treatment with or without sodium L-lactate. Mice were sacrificed 24 hours post-injury to assess neuronal death, microtubule disruption, oxidative damage, lactate shuttle enzyme activity, and cognitive impairment.
What was found
The abstract reports qualitative directions without numerical values or effect sizes. Astrocyte-specific PKM2 deletion exacerbated post-TBI neuronal death and worsened cognitive impairment. Conversely, post-TBI sodium L-lactate administration reduced neuronal death and improved cognitive outcomes.
Why it matters
This study highlights astrocytic PKM2 and lactate shuttle metabolism as critical determinants of neuronal survival following brain trauma. It provides preclinical mechanistic support for lactate administration as a potential neuroprotective strategy in acute TBI.
Limits
The study was conducted exclusively in a rodent model, limiting direct translation to human clinical TBI. The abstract provides no sample sizes, dosages, quantitative outcome values, or statistical precision estimates. Measurements were restricted to a single acute 24-hour time point.
Cited by
- supports Traumatic brain injury disrupts the ability of astrocytes to produce lactate in the brain.